NCT00909844View on ClinicalTrials.gov

Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up Study

PHASE3CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

April 30, 2015

Study Completion Date

January 31, 2016

Conditions
Precocious Puberty
Interventions
DRUG

Triptorelin (I.N.N.)

Decapeptyl® SR 11.25mg

Trial Locations (10)

31026

Hôpital des Enfants, Toulouse

33000

Medical Centre, Bordeaux

49033

Hôpital Hôtel Dieu (CHU), Angers

51092

American Memorial Hospital, Reims

65013

Hôpital de la Gespe, Tarbes

67100

Hôpital Hautepierre, Strasbourg

75019

Hôpital Robert Debré, Paris

76031

Hôpital Charles Nicolle, Rouen

76083

Hôpital Flaubert, Le Havre

06202

Hôpital Archet II, Nice

Sponsors

Lead Sponsor

Ipsen
All Listed Sponsors
lead

Ipsen

INDUSTRY

NCT00909844 - Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up Study | Biotech Hunter | Biotech Hunter